Skip to content

Syndax Pharmaceuticals

US · SNDX #2947 by market cap Listed 2016
17.03 -0.34 -1.96%
Live - 5344 symbols - heartbeat 68s ago · 2026-10-08 07:42
Pre-market 16.80 -1.35%
After-hours 17.20 +1.00%
Market cap
1.52B
P/B
100.77
EPS
-3.29
Reader sentiment Are you bullish or bearish on SNDX?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Goldman Sachs Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $34
    Market Newswire · 2026/7/15
  • Rating change
    Jefferies Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $37
    Market Newswire · 2026/5/2
  • Rating change
    Stifel Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $46
    Market Newswire · 2026/7/15
  • Company notice
    Syndax Pharmaceuticals: Syndax Pharmaceuticals, Inc. - Flex Position Consolidation Option Symbol: 1SNDX
    OCC · 2025/8/12
  • Rating change
    H.C. Wainwright Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/7/15
  • H.C. Wainwright Sticks to Its Buy Rating for Syndax Pharmaceuticals (SNDX)
    TipRanks · 2026/9/22
  • Rating change
    TD Cowen Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating
    Market Newswire · 2026/7/16
  • Rating change
    Guggenheim Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $31
    Market Newswire · 2026/6/12
  • Rating change
    A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $29 to $40
    Market Newswire · 2026/5/1
  • H.C. Wainwright Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $38
    Market Newswire · 2026/10/1
  • Citi Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $57
    Market Newswire · 2026/9/29
  • Stifel Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/8/14
  • Rating change
    A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $26 to $57
    Market Newswire · 2026/8/5
  • Rating change
    Stifel Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Raises Target Price to $46
    Market Newswire · 2026/5/4
  • Rating change
    Barclays Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $37
    Market Newswire · 2026/7/20
  • UBS Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $33
    Market Newswire · 2026/8/21
  • Rating change
    J.P. Morgan Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $40
    Market Newswire · 2026/8/11
  • Rating change
    BofA Securities Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $26
    Market Newswire · 2026/8/5
  • Rating change
    UBS Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $37
    Market Newswire · 2026/5/13
  • Rating change
    BofA Securities Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $29
    Market Newswire · 2026/7/22

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 07:42:13 · For reference only, not investment advice and not tailored to your situation.